Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05636618
Title Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors (212-Pb-VMT)
Acronym 212-Pb-VMT
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Viewpoint Molecular Targeting
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.